Emily A. Hull-Ryde is a researcher and manager in the Assay/Development and Compound Profiling Group for the Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina Chapel Hill. Ms. Hull-Ryde has extensive expertise in kinase biology from her twenty-two years of assay development, lead progression